Development of target antigen-displaying virus-like particles (VLPs) for the generation of antibodies using hybridoma technology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hannover, Gottfried Wilhelm Leibniz Universität, Dissertation, 2024
- Schlagwort
-
Antikörper
Antigenpräsentation
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Gottfried Wilhelm Leibniz Universität
- (wann)
-
2024
- Urheber
- DOI
-
10.15488/16095
- URN
-
urn:nbn:de:101:1-2024021501112703428551
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schatz, Stefanie
- Gottfried Wilhelm Leibniz Universität
Entstanden
- 2024
Ähnliche Objekte (12)
Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency
Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency
Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
Evaluation of antigen-displaying adeno-associated virus-like particles (AAVLPs) as future candidates for personalized cancer vaccination
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Displaying the prion protein on virus-like particles : a novel tool towards vaccination
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition